Evalyn E.A.P. Mulder

1.0k total citations
16 papers, 207 citations indexed

About

Evalyn E.A.P. Mulder is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Evalyn E.A.P. Mulder has authored 16 papers receiving a total of 207 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 7 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Evalyn E.A.P. Mulder's work include Cutaneous Melanoma Detection and Management (9 papers), CAR-T cell therapy research (5 papers) and Melanoma and MAPK Pathways (5 papers). Evalyn E.A.P. Mulder is often cited by papers focused on Cutaneous Melanoma Detection and Management (9 papers), CAR-T cell therapy research (5 papers) and Melanoma and MAPK Pathways (5 papers). Evalyn E.A.P. Mulder collaborates with scholars based in Netherlands, United States and Australia. Evalyn E.A.P. Mulder's co-authors include Shiromani Janki, Jan N.M. IJzermans, T.C.K. Tran, Dirk J. Grünhagen, Cornelis Verhoef, Astrid A.M. van der Veldt, Antien L. Mooyaart, D. Verver, Dennie Tempel and Tamar Nijsten and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Transplantation.

In The Last Decade

Evalyn E.A.P. Mulder

16 papers receiving 205 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Evalyn E.A.P. Mulder Netherlands 7 98 62 48 45 32 16 207
Neha Chopra United Kingdom 8 75 0.8× 29 0.5× 76 1.6× 25 0.6× 19 210
Colleen McCormick United States 7 100 1.0× 57 0.9× 35 0.7× 5 0.1× 19 293
Katerina Shulman Israel 9 184 1.9× 29 0.5× 64 1.3× 5 0.1× 23 266
Deborah Farr United States 9 35 0.4× 54 0.9× 10 0.2× 13 0.3× 34 184
Berislav Vekić Serbia 10 44 0.4× 67 1.1× 20 0.4× 6 0.1× 29 245
Élise Dumas France 7 124 1.3× 14 0.2× 24 0.5× 5 0.1× 25 195
Shobhit Baijal United Kingdom 6 91 0.9× 39 0.6× 18 0.4× 6 0.1× 27 155
Christina Henson United States 9 68 0.7× 31 0.5× 36 0.8× 11 0.2× 39 205
Haoyu Zhang United States 8 43 0.4× 64 1.0× 62 1.3× 3 0.1× 30 268
Martijn GH van Oijen Netherlands 6 25 0.3× 53 0.9× 15 0.3× 20 0.4× 7 133

Countries citing papers authored by Evalyn E.A.P. Mulder

Since Specialization
Citations

This map shows the geographic impact of Evalyn E.A.P. Mulder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evalyn E.A.P. Mulder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evalyn E.A.P. Mulder more than expected).

Fields of papers citing papers by Evalyn E.A.P. Mulder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evalyn E.A.P. Mulder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evalyn E.A.P. Mulder. The network helps show where Evalyn E.A.P. Mulder may publish in the future.

Co-authorship network of co-authors of Evalyn E.A.P. Mulder

This figure shows the co-authorship network connecting the top 25 collaborators of Evalyn E.A.P. Mulder. A scholar is included among the top collaborators of Evalyn E.A.P. Mulder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evalyn E.A.P. Mulder. Evalyn E.A.P. Mulder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Mulder, Evalyn E.A.P., Antien L. Mooyaart, Anne Brecht Francken, et al.. (2023). Clinical evaluation of the clinicopathologic and gene expression profile (CP-GEP) in patients with melanoma eligible for sentinel lymph node biopsy: A multicenter prospective Dutch study. European Journal of Surgical Oncology. 49(12). 107249–107249. 11 indexed citations
2.
Mulder, Evalyn E.A.P., Iva Johansson, Dirk J. Grünhagen, et al.. (2023). Using a clinicopathologic and gene expression (CP-GEP) model to identify stage I-II melanoma patients at risk for disease relapse. European Journal of Surgical Oncology. 49(2). e33–e34. 1 indexed citations
3.
Joode, Karlijn de, Evalyn E.A.P. Mulder, Arjen Joosse, et al.. (2022). The meaning of screening: detection of brain metastasis in the adjuvant setting for stage III melanoma. ESMO Open. 7(6). 100600–100600. 4 indexed citations
4.
Mulder, Evalyn E.A.P., Jeffrey Damman, D. Verver, et al.. (2022). Histopathological and immunological spectrum in response evaluation of talimogene laherparepvec treatment and correlation with durable response in patients with cutaneous melanoma. Melanoma Research. 32(4). 249–259. 2 indexed citations
5.
Mulder, Evalyn E.A.P., D. Verver, Thierry P. P. van den Bosch, et al.. (2022). Mesenchymal-epithelial transition factor (MET) immunoreactivity in positive sentinel nodes from patients with melanoma. Annals of Diagnostic Pathology. 58. 151909–151909. 1 indexed citations
6.
Mulder, Evalyn E.A.P., Sophie J. M. Reijers, Sara Balduzzi, et al.. (2022). Single agent Talimogene Laherparepvec for stage IIIB-IVM1c melanoma patients: A systematic review and meta-analysis. Critical Reviews in Oncology/Hematology. 175. 103705–103705. 9 indexed citations
7.
Mulder, Evalyn E.A.P., Dirk J. Grünhagen, Tessa M. van Ginhoven, et al.. (2022). Successful use of a magnetic localisation system for non-palpable malignant lesions: a single centre experience.. European Journal of Surgical Oncology. 48(2). e141–e141. 3 indexed citations
8.
Mulder, Evalyn E.A.P., Iva Johansson, Dirk J. Grünhagen, et al.. (2022). Using a Clinicopathologic and Gene Expression (CP-GEP) Model to Identify Stage I–II Melanoma Patients at Risk of Disease Relapse. Cancers. 14(12). 2854–2854. 20 indexed citations
9.
Mulder, Evalyn E.A.P., Antien L. Mooyaart, Jvalini Dwarkasing, et al.. (2022). Use of Merlin Assay to identify patients with a low-risk for SN metastasis in a prospective multicenter Dutch study of a primary melanoma gene-signature (CP-GEP model) to predict sentinel node status during COVID-19.. Journal of Clinical Oncology. 40(16_suppl). 9571–9571. 3 indexed citations
10.
Mulder, Evalyn E.A.P., Dirk J. Grünhagen, Cornelis Verhoef, et al.. (2021). Cost-effectiveness of adjuvant systemic therapies for patients with high-risk melanoma in Europe: a model-based economic evaluation. ESMO Open. 6(6). 100303–100303. 12 indexed citations
11.
Mulder, Evalyn E.A.P., D. Verver, Lukas B. Been, et al.. (2021). False positive FDG uptake in melanoma patients treated with talimogene laherparepvec (T‐VEC). Journal of Surgical Oncology. 124(7). 1161–1165. 1 indexed citations
12.
Mulder, Evalyn E.A.P., Jvalini Dwarkasing, Dennie Tempel, et al.. (2020). Validation of a clinicopathological and gene expression profile model for sentinel lymph node metastasis in primary cutaneous melanoma*. British Journal of Dermatology. 184(5). 944–951. 38 indexed citations
13.
Mulder, Evalyn E.A.P., Jvalini Dwarkasing, Loes M. Hollestein, et al.. (2019). Validation of a clinicopathological and gene expression profile (CP-GEP) model for sentinel lymph node metastasis in primary cutaneous melanoma. Annals of Oncology. 30. v540–v540. 5 indexed citations
14.
Mulder, Evalyn E.A.P., Shiromani Janki, Türkan Terkivatan, et al.. (2018). 3D Endoscopic Donor Nephrectomy Versus Robot-assisted Donor Nephrectomy. Transplantation. 102(6). e295–e300. 4 indexed citations
15.
Janki, Shiromani, Evalyn E.A.P. Mulder, Jan N.M. IJzermans, & T.C.K. Tran. (2016). Ergonomics in the operating room. Surgical Endoscopy. 31(6). 2457–2466. 79 indexed citations
16.
Janki, Shiromani, Leonienke F. C. Dols, Reinier Timman, et al.. (2016). Five-year follow-up after live donor nephrectomy - cross-sectional and longitudinal analysis of a prospective cohort within the era of extended donor eligibility criteria. Transplant International. 30(3). 266–276. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Neha Chopra Breakdown of academic impact, for papers by Colleen McCormick Breakdown of academic impact, for papers by Katerina Shulman Breakdown of academic impact, for papers by Deborah Farr Breakdown of academic impact, for papers by Berislav Vekić Breakdown of academic impact, for papers by Élise Dumas Breakdown of academic impact, for papers by Shobhit Baijal Breakdown of academic impact, for papers by Christina Henson Breakdown of academic impact, for papers by Haoyu Zhang Breakdown of academic impact, for papers by Martijn GH van Oijen
Rankless by CCL
2026